/west%20pharmaceutical%20company%20in%20dublin%20By%20frank.jpeg)
Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products. Valued at $25.7 billion by market cap, the company’s technologies include the design and manufacture of packaging components, research and development of drug delivery systems, and contract laboratory services and other services. The leading manufacturer of containment and delivery systems is expected to announce its fiscal third-quarter earnings for 2026 in the near term.
Ahead of the event, analysts expect WST to report a profit of $2.18 per share on a diluted basis, up 11.2% from $1.96 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.
